Most Americans would prefer brand-name drugs—but end up buying generic versions because of the cost, new consumer research ...

Alberta Health Services (AHS) issued a $28-million prepayment to Edmonton importer MHCare for a pharmaceutical order that ...

A new, generic, non-steroidal anti-inflammatory drug (NSAID) is now available for managing osteoarthritis (OA) pain in horses ...

Collectively, the top eight blockbuster drugs of 2024 generated over $116 billion in sales last year. Looking closer at these ...

Robert F. Kennedy Jr. won Senate confirmation as the nation’s health secretary on Feb. 13.

Sour Patch Kids-maker Mondelëz Canada Inc. (“MCI”) has filed a trademark lawsuit against a THC-infused gummies maker selling ...

Last year was a pivotal year for the pharmaceutical industry. Under the IRA’s Medicare Drug Price Negotiation Program (the ...

Quality, affordable health care is crucial to aging well, and Medicare makes it possible for millions of older adults in the ...

GlaxoSmithKline Pharmaceuticals on Friday said its net profit increased over five-fold to Rs 229 crore for the third quarter ended December 31, 2024.

Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.